-+ 0.00%
-+ 0.00%
-+ 0.00%

Visionary Holdings Subsidiary Signs $12M Exclusive Distribution Agreement For Anti-Aging Product, Premier Regenerative Complex-President Super Injection, In Cooperation With Huajin China

Benzinga·03/02/2026 14:33:41
Listen to the news

Visionary Holdings Inc. (NASDAQ:GV) ("the Company"), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited ("GV Hong Kong"), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin China Investment Company("Huajin China"), alongside the Board-approved divestiture of its non-core education business.

These strategic actions mark the Company's formal transition into a commercialization acceleration phase within the high-end medical aesthetics sector.